Dror Marchaim
Impact in
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 51
-
- Antibiotic Use and Resistance 21
- Co-authors
- Keith S. Kaye (45 shared papers)Jason M. Pogue (24 shared papers)Yehuda Carmeli (5 shared papers)Shiri Navon‐Venezia (5 shared papers)Mitchell J. Schwaber (3 shared papers)Paul Lephart (22 shared papers)Kayoko Hayakawa (25 shared papers)Teena Chopra (16 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (14 papers)American Journal of Infection Control (10 papers)Antimicrobial Agents and Chemotherapy (8 papers)Antibiotics (4 papers)Open Forum Infectious Diseases (4 papers)
- Partner nations
- IsraelUnited StatesJapan
In The Last Decade
Dror Marchaim
78 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 1.5k
- Applied Microbiology and Biotechnology 447
- Endocrinology 405
- Clinical Biochemistry 356
- Pharmacology 417
Countries citing papers authored by Dror Marchaim
This map shows the geographic impact of Dror Marchaim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Marchaim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Marchaim more than expected).
Fields of papers citing papers by Dror Marchaim
This network shows the impact of papers produced by Dror Marchaim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Marchaim. The network helps show where Dror Marchaim may publish in the future.
Co-authors
The 25 scholars most cited alongside Dror Marchaim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 167 | |
| 2 | 2007 | 137 | |
| 3 | 2014 | 114 | |
| 4 | 2012 | 111 | |
| 5 | 2015 | 111 | |
| 6 | 2012 | 100 | |
| 7 | 2016 | 85 | |
| 8 | 2014 | 80 | |
| 9 | 2013 | 72 | |
| 10 | 2010 | 69 | |
| 11 | 2015 | 69 | |
| 12 | 2012 | 66 | |
| 13 | 2012 | 63 | |
| 14 | 2008 | 60 | |
| 15 | 2011 | 59 | |
| 16 | 2012 | 57 | |
| 17 | 2016 | 55 | |
| 18 | 2016 | 51 | |
| 19 | 2007 | 50 | |
| 20 | 2012 | 48 |
About Dror Marchaim
Dror Marchaim is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology, Pharmacology, Epidemiology and Infectious Diseases, having authored 80 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (51 papers), Antibiotic Use and Resistance (21 papers), Antibiotics Pharmacokinetics and Efficacy (18 papers), Bacterial Identification and Susceptibility Testing (12 papers), Urinary Tract Infections Management (9 papers), Antimicrobial Resistance in Staphylococcus (8 papers), Nosocomial Infections in ICU (7 papers) and Infection Control in Healthcare (4 papers). The work is most often cited by research in Molecular Medicine (1.5k citations), Applied Microbiology and Biotechnology (447 citations), Endocrinology (405 citations), Clinical Biochemistry (356 citations) and Pharmacology (417 citations). Dror Marchaim has collaborated with scholars based in Israel, United States and Japan. Frequent co-authors include Keith S. Kaye, Jason M. Pogue, Yehuda Carmeli, Shiri Navon‐Venezia, Mitchell J. Schwaber, Paul Lephart, Kayoko Hayakawa, Teena Chopra, David Katz and Sandra S. Richter. Their work appears in journals such as Infection Control and Hospital Epidemiology, American Journal of Infection Control, Antimicrobial Agents and Chemotherapy, Antibiotics and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.